24,99 €
inkl. MwSt.
Versandfertig in 6-10 Tagen
12 °P sammeln
Andere Kunden interessierten sich auch für
![Haemonchosis in Experimentally Infected Ethiopian highland sheep]( "Haemonchosis in Experimentally Infected Ethiopian highland sheep")
Haemonchosis in Experimentally Infected Ethiopian highland sheep24,99 €![Immunothérapie à l'aide d'IgY aviaire chez des souris infectées expérimentalement]( "Immunothérapie à l'aide d'IgY aviaire chez des souris infectées expérimentalement")
Immunothérapie à l'aide d'IgY aviaire chez des souris infectées expérimentalement23,99 €![Immunoterapia con IgY aviarie in topi infettati sperimentalmente]( "Immunoterapia con IgY aviarie in topi infettati sperimentalmente")
Immunoterapia con IgY aviarie in topi infettati sperimentalmente23,99 €![Immuntherapie mit aviärem IgY bei experimentell infizierten Mäusen]( "Immuntherapie mit aviärem IgY bei experimentell infizierten Mäusen")
Immuntherapie mit aviärem IgY bei experimentell infizierten Mäusen35,90 €![Avian flu, migratory birds and poultry health]( "Avian flu, migratory birds and poultry health")
Avian flu, migratory birds and poultry health36,99 €![Evaluation of the phagocytosis of CAE virus-infected macrophages]( "Evaluation of the phagocytosis of CAE virus-infected macrophages")
Evaluation of the phagocytosis of CAE virus-infected macrophages24,99 €![Guide to Biosafety in Animal Facilities (Animal Houses)]( "Guide to Biosafety in Animal Facilities (Animal Houses)")
Guide to Biosafety in Animal Facilities (Animal Houses)40,99 €
Trypanosoma evansi is a flagellated protozoan that affects cattle, sheep, goats, asses, cats and pigs. The disease is particularly important in horses and is known as "chair sickness" due to the characteristic locomotion deficits in infected animals. Various therapeutic drugs have been recommended for prophylaxis and control of the protozoan, but over the years these drugs have lost their efficacy and the protozoan seems to develop resistance. The production and use of avian antibodies has aroused great interest in the scientific community due to the diversity of diagnostic and therapeutic applications. Due to their phylogenetic distance, immune diversification mechanisms and the ability to transfer serum immunoglobulins to egg yolk, a number of advantages are now recognised when using avian antibodies instead of mammalian antibodies. In this study, a specific immunoglobulin against T. evansi was produced by immunising chickens using an isolate of the protozoan. Therapeutic efficacy was tested in Rattus norvegicus.